Reference health
Immunohistochemical and <scp>FISH</scp> analysis of <scp>EGFR</scp> and its prognostic value in patients with oral squamous cell carcinoma
26/26 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 26 checked references that resolve
resolves10.1200/JCO.2008.21.4197
Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024
resolves10.1016/j.oraloncology.2012.06.016
Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature
resolves10.1200/JCO.1993.11.10.1873
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
resolves10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X
Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
resolves10.1038/sj.bjc.6602941
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival
resolves10.1016/j.oraloncology.2007.02.008
Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas
resolves10.1016/j.oraloncology.2003.08.010
Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?
resolves10.1586/era.12.91
Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma
resolves10.1158/1078-0432.CCR-05-0420
Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis
resolves10.1158/0008-5472.338.65.1
Novel Prognostic Value of Nuclear Epidermal Growth Factor Receptor in Breast Cancer
resolves10.1093/jnci/90.11.824
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
resolves10.1016/j.ijrobp.2003.07.010
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy
resolves10.1016/S0002-9440(10)64592-0
High-Throughput Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression in Urinary Bladder Cancer
resolves10.1002/hed.23087
Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer
resolves10.1007/BF02893450
Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas
resolves10.1111/j.1601-0825.2006.01280.x
Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma
resolves10.1200/JCO.2006.07.2587
Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas
resolves10.1016/S1368-8375(01)00051-3
Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions
resolves10.1200/JCO.2006.06.6605
Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer
resolves10.1158/0008-5472.CAN-05-2994
Prognostic Value of an Activation State Marker for Epidermal Growth Factor Receptor in Tissue Microarrays of Head and Neck Cancer
The 5 references without a DOI — listed, not checked
no DOI — not checkedTissue microarrays for gene amplification surveys in many different tumor types
no DOI — not checkedTissue microarray analysis reveals site‐specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma
no DOI — not checkedDifferences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell
no DOI — not checkedCCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas
no DOI — not checkedCombination of EGFR, HER‐2/neu, and HER‐3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1111/jop.12111"><img src="https://citestamp.com/citestamped/10.1111/jop.12111/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1111/jop.12111)